Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

RSS NEWS FEED

Home

PharmedOut is an independent, publicly funded project that empowers physicians to identify and counter inappropriate pharmaceutical promotion practices. PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.

Pharma-Free CME

More than 200 free web-based CME credits are available without cost.

Resources by Topic

Drug promotion, drug information, evidence-based
medicine, docs and pharma, industry-sponsored research, conflict of interest, direct-to-consumer advertising, drug reps, and other topics.

Resources by Type

Articles, reports, slide shows, databases, subscribables, and links to other organizations and websites.

Teaching Tools

Materials for educators.

---

PharmedOut Publications

PharmedOut in the Media

News Archive

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Stealth Marketers
Shilling for pharma on NPR Slate

---

Psychiatry Handbook Linked to Drug Industry
COIs in over half of new working group members NYT (read Center for Science in the Public Interest article)

---

Legislators: Glaxo Letter on Gift Ban May Backfire
Does MA have a “strong anti-biopharmaceutical streak?” Boston Herald (read additional article)

---

Glaxo Tries to Corner Weight Loss Market
Tells FDA to deny dietary supplement claims Pharmalot

---

Anti-Psychotic Drug Use Soars in UK & US Children
6x higher use in US AP (read study)

---

Chantix Recommended to Quit Smoking
PHS guideline author was Pfizer consultant LA Times

---

Merck Wrote Drug Studies for Doctors
Trial deaths underreported NYT (read ghostwriting study; mortality study; JAMA editorial)

---

Drugmakers Didn't Begin 1,044 Promised U.S. Studies
62% of postmarketing studies Bloomberg

---

Many Ads For Psych Meds Are Unsubstantiated
Half of drug claims unsupported Pharmalot (read study)

---

Antipsychotics and Pneumonia in Elderly
60% increase; more risk with atypicals Journal of the American Geriatrics Society

---

AstraZeneca in Pact With Rival to Delay Generic
Ranbaxy will formulate Nexium NYT

---

Panel’s Bipartisan View: F.D.A. Is Underfinanced
Congress considers more funding NYT

---

Commentary

Countering the Drug Salesmen
Academic detailing bill NYT

---

Click HERE to read the entire news archives